WASHINGTON—The Trump administration said it isn’t planning to impose tariffs on generic drugs from foreign countries, after months of wrangling over whether to impose levies on the vast majority of ...

MUMBAI: In a move expected to bring major relief to thousands of patients, the Brihanmumbai Municipal Corporation (BMC) has cleared a proposal to set up generic drug outlets inside its hospitals, ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...

The federal government will not impose tariffs on generic pharmaceuticals manufactured overseas, and instead focus on brand-name drugs, according to an Oct. 8 report from The Wall Street Journal. In a ...

They have the same active ingredients—but experts say there are some key factors that set these medications apart at the pharmacy counter. One of the biggest is cost. An employee inspects medications ...

The Trump administration has abandoned plans for tariffs on imported generic drugs, a move bringing significant relief to Indian pharmaceutical companies. This decision averts potential price hikes ...

Panaji: India is emerging as the pharmacy of the world through generics, said former director of Central Drug Research Institute (CDRI), Lucknow, Dr Madhu Dikshit. Speaking on the topic ‘From ancient ...

The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications ...

The US Food and Drug Administration (FDA) has launched a new pilot programme to fast-track abbreviated new drug applications (ANDAs) of generic drugs for companies that make and test them entirely ...

The pharma sector is in focus and all pharma stocks are surging. This is after a Wall Street Journal report indicated that the Trump administration may not impose tariffs on generic medicines. There ...

Thanks to new settlement agreements with three generic drug makers, Gilead Sciences has extended the expected life span of its flagship HIV treatment Biktarvy by as many years. Gilead has struck ...